IPEC publishes GDP Audit Guideline for Pharmaceutical Excipients
Recommendation

10/11 February 2026
Risk analysis, preventive measures and incident management
The IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients has been revised and the new version has been published. The previous version was published in 2008. The original version goes back to 2000.
The new document is designed in a questionnaire format to assist in evaluating the practices and quality systems of distributors who sell, store or repackage pharmaceutical excipients or any combination thereof. The audit guideline should be considered as the audit tool used in the evaluation of excipient distributors' GDP compliance, in accordance with the current IPEC GDP Guideline for Pharmaceutical Excipients (2006), which describes these principles in detail
Source: IPEC Press Release
Here you will find the IPEC Good Distribution Practice (GDP) Audit Guideline for Pharmaceutical Excipients
You can download the word version of the Guide here
Related GMP News
20.01.2026Documents to Support your GDP Audit
20.01.2026Questions and Answers on Transport and Vehicle Qualification (Part 3)
20.01.2026The GDP Non-Compliance Reports of 2025 - An Overview
16.12.2025How Valuable Are Commercial GDP Certificates?
16.12.2025Questions and Answers on Transport and Vehicle Qualification (Part 2)
16.12.2025When is a WDA Required? - Discussion of the ECA GDP Survey Results


